Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

856077

registered interest
date	06/03/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Dogs: Theft
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what steps her Department has taken to reduce dog theft in the last 12 months.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	131243
answer	answer is ministerial correction date of answer 12/03/2018 answer text <p>The Government understands the distress that can be caused by the theft of a pet. It is therefore important that these crimes, when they take place, are reported to the police so that they can be investigated and, where appropriate, the perpetrators taken through the courts and given appropriate sentences.</p><p>In 2017-18 the Government is providing police forces in England and Wales with direct Government funding worth over £7.5 billion to tackle all types of crime. As far as the police response to individual incidents are concerned, it is for Chief Constables and Police and Crime Commissioners, as operational leaders and elected local representatives, to decide how best to deploy resources to manage and respond to crime and local priorities.</p> answering member constituency Louth and Horncastle answering member printed Victoria Atkins question first answered 12/03/2018 17:47:44 answering member 4399 label Biography information for Victoria Atkins
tabling member	4649 label Biography information for Thelma Walker

855579

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding his Department has allocated to medical research for the development of new medicines in each of the last three years.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130886
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The Department funds research via the National Institute for Health Research (NIHR).</p><p> </p><p>The types of biomedical and health related research that are funded by NIHR and other funders can be classified using the Health Research Classification System (HRCS). Whilst HRCS does not have a category that is specifically ‘new medicines’, HRCS codes 5.1 and 6.1 relate to the development and evaluation of pharmaceutical treatments and therapeutic interventions and can be used to classify NIHR Programme Spend. It is possible that these codes may include some evaluation of existing medicines.</p><p> </p><p>In addition, the NIHR Clinical Research Network (CRN) undertakes research which supports clinical trials into pharmaceutical treatments and therapeutic interventions. CRN funding data can be calculated based on the number of recruiting 'Clinical Trial of an Investigational Medicinal Product (CTIMP)' studies within the CRN Portfolio.</p><p> </p><p>NIHR programme research spend classified under HRCS codes 5.1 and 6.1 and CRN CTIMP spend over the last three years where complete data is available is shown in the following table:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>NIHR Programme Spend</p></td><td><p>£34,204,157.67</p></td><td><p>£36,655,975.32</p></td><td><p>£39,011,490.62</p></td></tr><tr><td><p>CRN spend</p></td><td><p>£76,600,272.00</p></td><td><p>£77,676,259.00</p></td><td><p>£77,036,034.00</p></td></tr><tr><td><p> </p></td><td><p>£110,804,429.67</p></td><td><p>£114,332,234.32</p></td><td><p>£116,047,524.62</p></td></tr></tbody></table><p><br>Research which may also contribute to the development and evaluation of pharmaceutical treatments and therapeutic interventions carried out across NIHR Infrastructure is not coded by the HRCS scheme so cannot be wholly attributed to individual research topics.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 16:43:10 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker

855580

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the level of funding from the public purse to be allocated to research for medicines in each of the next three years.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130887
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The Department funds research via the National Institute for Health Research (NIHR).</p><p> </p><p>The NIHR welcomes funding applications for research into a wide range of areas but does not usually ring-fence funds for particular topics. Awards are made in open competition on the basis of importance of topics to patients and heath and care services, value for money, and scientific quality judged through peer review. The amount of future NIHR funding in specific topic areas will depend on the quality and quantity of research proposals submitted to NIHR for review. As such, NIHR does not hold projected funding allocations specifically for research into medicines.</p><p> </p><p>Information on individual projects funded by the NIHR can be found at:</p><p> </p><p><a href="https://www.journalslibrary.nihr.ac.uk/programmes/" target="_blank">https://www.journalslibrary.nihr.ac.uk/programmes/</a></p><p> </p><p>However, NIHR does hold information on previous spend on the types of biomedical and health related research that are funded by NIHR and other funders, classified using the Health Research Classification System (HRCS). Whilst HRCS does not have a category that is specifically ‘new medicines’, HRCS codes 5.1 and 6.1 relate to the development and evaluation of pharmaceutical treatments and therapeutic interventions and can be used to classify NIHR Programme Spend. It is possible that these codes may include some evaluation of existing medicines.</p><p> </p><p>In addition, the NIHR Clinical Research Network (CRN) undertakes research which supports clinical trials into pharmaceutical treatments and therapeutic interventions. CRN funding data can be calculated based on the number of recruiting ' Clinical Trial of an Investigational Medicinal Product (CTIMP) ' studies within the CRN Portfolio.</p><p> </p><p>NIHR programme research spend classified under HRCS codes 5.1 and 6.1 and CRN CTIMP spend over the last three years where complete data is available is set out below:</p><p> </p><table><tbody><tr><td><p> </p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td></tr><tr><td><p>NIHR Programme Spend</p></td><td><p>£34,204,157.67</p></td><td><p>£36,655,975.32</p></td><td><p>£39,011,490.62</p></td></tr><tr><td><p>CRN spend</p></td><td><p>£76,600,272.00</p></td><td><p>£77,676,259.00</p></td><td><p>£77,036,034.00</p></td></tr><tr><td><p> </p></td><td><p>£110,804,429.67</p></td><td><p>£114,332,234.32</p></td><td><p>£116,047,524.62</p></td></tr></tbody></table><p><br>Research which may also contribute to the development and evaluation of pharmaceutical treatments and therapeutic interventions carried out across NIHR Infrastructure is not coded by the HRCS scheme so cannot be wholly attributed to individual research topics.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 16:36:35 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker

855581

registered interest
date	05/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure that (a) funding from the public purse for medical research is transparent; and (b) that medicines produced a result of funding from the public purse are affordable.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130888
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The National Institute for Health Research (NIHR) is funded through the Department to improve the health and wealth of the nation through research. Full and open access to the knowledge generated by research is of the utmost importance to the NIHR. The NIHR commitment to transparency, the NIHR Journals Library, open access policy, and endorsement of the World Health Organization joint statement on the disclosure of results ensures that ideas and knowledge derived from publicly funded research are made available and accessible for public use.</p><p> </p><p>The National Institute for Health and Care Excellence technology appraisal guidance and the associated funding requirement plays an important role in ensuring that patients have access to cost-effective new medicines, including medicines developed from public research.</p><p> </p><p>The recent Government and partner bodies response to the Accelerated Access Review sets out how we will work with industry and the health system to create a streamlined and sophisticated approvals system so that cost-effective breakthrough products – be they drugs, devices, digital or diagnostics – can get into the National Health Service as fast as possible.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 13/03/2018 13:57:44 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4649 label Biography information for Thelma Walker

855682

registered interest
date	05/03/2018
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, when his Department plans to respond to the correspondence dated 19 December 2017 from the hon. Member for Colne Valley on a constituent’s concerns over EU nationals.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130988
answer	answer is ministerial correction date of answer 13/03/2018 answer text <p>The response to the hon. Member’s correspondence dated 19 December 2017 regarding a constituent’s concerns about EU nationals was dispatched by the Department for Exiting the European Union on 22 February 2018.</p> answering member constituency Wycombe answering member printed Mr Steve Baker question first answered 13/03/2018 16:16:49 answering member 4064 label Biography information for Mr Steve Baker
tabling member	4649 label Biography information for Thelma Walker

855683

registered interest
date	05/03/2018
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Members: Correspondence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, when his Department plans to respond to the correspondence dated 11 January 2018 from the hon. Member for Colne Valley on a constituent’s concerns about leaving the EU.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130989
answer	answer is ministerial correction date of answer 15/03/2018 answer text <p>The Department for Exiting the European Union responded to the hon. Member for Colne Valley’s correspondence regarding her constituent’s concerns about leaving the EU on Monday 12 March 2018.</p> answering member constituency Worcester answering member printed Mr Robin Walker question first answered 15/03/2018 13:57:57 answering member 4091 label Biography information for Mr Robin Walker
tabling member	4649 label Biography information for Thelma Walker

853329

registered interest
date	02/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nabiximols
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on reducing the cost of the drug Sativex in order to allow that drug to be prescribed to people suffering from MS.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	130778
answer	answer is ministerial correction date of answer 12/03/2018 answer text <p>Sativex is licensed for the treatment of moderate to severe spasticity in multiple sclerosis (MS). It is normally prescribed on the National Health Service by a specialist doctor with experience of treating MS spasticity – consultant neurologists, consultant rehabilitation specialists and consultant pain specialists.</p><p> </p><p>When the National Institute for Health and Care Excellence (NICE) published its guideline on the treatment of adults with MS in 2014, it recommended that Sativex should not be offered as an option to treat spasticity in people with MS because it is not a cost effective treatment. NICE is responsible for determining whether its guidance should be updated following the publication of any significant new evidence.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/03/2018 17:05:09 answering member 4067 label Biography information for Steve Brine
tabling member	4649 label Biography information for Thelma Walker

849982

registered interest
date	26/02/2018
answering body	Cabinet Office
answering dept id	53
answering dept short name	Cabinet Office
answering dept sort name	Cabinet Office
hansard heading	Zero Hours Contracts: Colne Valley
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Minister for the Cabinet Office, how many people who live in Colne Valley constituency, are employed on zero-hour contracts.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	129550
answer	answer is ministerial correction date of answer 06/03/2018 answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 06/03/2018 12:25:13 answering member 1609 label Biography information for Chloe Smith attachment 1 file name PQ 129550.pdf title UKSA Response
tabling member	4649 label Biography information for Thelma Walker

849983

registered interest
date	26/02/2018
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Carbon Emissions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what discussions he has had with the Secretary of State for Housing, Communities and Local Government, on Government support for (a) local authorities and (b) communities to meet the UK's targets for carbon emissions.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	129551
answer	answer is ministerial correction date of answer 12/03/2018 answer text <p>Climate change is one of the most urgent and pressing challenges we face today, and the UK Government is committed to tackling it. The Clean Growth Strategy, published in October 2017, sets out the Government’s ambitious plans for decarbonising the economy through the 2020s. We continue to engage with Departments on implementing the strategy, including the Ministry for Housing, Communities and Local Government.</p><p>The joint BEIS and MHCLG office for Cities and Local Growth works closely with Ministers from both Departments, as well as Local Enterprise Partnerships and local authorities. BEIS has launched a Local Energy Programme which will provide support to Local Enterprise Partnerships and local authorities to help them implement energy projects which benefit their communities. To date, £7m has been committed to this. Additionally a further £16m has been provided to Local Authorities by the Heat Networks Delivery Unit (HNDU) and £24m through the pilot phase of the £320m Heat Networks Investment Project (HNIP). Local Authorities can also bid for funding in the main scheme of HNIP.</p> answering member constituency Devizes answering member printed Claire Perry question first answered 12/03/2018 16:50:30 answering member 3974 label Biography information for Claire Perry
tabling member	4649 label Biography information for Thelma Walker

849985

registered interest
date	26/02/2018
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Wind Power
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is taking to increase the production of electricity through community wind projects.
tabling member constituency	Colne Valley
tabling member printed	Thelma Walker
uin	129553
answer	answer is ministerial correction date of answer 06/03/2018 answer text <p>The Government’s National Planning Policy Framework (NPPF), which the Ministry of Housing, Communities and Local Government leads on, encourages local authorities and neighbourhood planning bodies to set out positive policies to support community-led initiatives for renewable and low carbon energy. The NPPF also encourages authorities to identify opportunities where developments can draw their energy supply from decentralised, renewable or low carbon energy supply systems.</p><p> </p><p>We are working with delivery partners to consider how communities wanting renewable projects can be best supported to deliver these cost-effectively. Community wind projects can be supported through the Feed In Tariff (FIT). We have reintroduced FIT pre-accreditation, including an extra six months’ validity period for community energy projects. Additionally the Rural Community Energy Fund (RCEF) provides support to community groups in rural areas for development and implementation of energy projects, including wind. RCEF is jointly funded by the Department for Business, Energy and Industrial Strategy and the Department for Environment, Food and Rural Affairs (DEFRA), and is managed on behalf of Government by DEFRA.</p><p> </p> answering member constituency Devizes answering member printed Claire Perry question first answered 06/03/2018 14:23:24 answering member 3974 label Biography information for Claire Perry
tabling member	4649 label Biography information for Thelma Walker